Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$780M |
| 2 |
Uber
UBER
|
+$708M |
| 3 |
Goldman Sachs
GS
|
+$569M |
| 4 |
Microsoft
MSFT
|
+$430M |
| 5 |
Netflix
NFLX
|
+$415M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$973M |
| 2 |
Intuitive Surgical
ISRG
|
+$872M |
| 3 |
Nike
NKE
|
+$844M |
| 4 |
Edwards Lifesciences
EW
|
+$805M |
| 5 |
Corpay
CPAY
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.66% |
| 2 | Consumer Discretionary | 19.04% |
| 3 | Healthcare | 13.04% |
| 4 | Communication Services | 12.22% |
| 5 | Financials | 10.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Mayville Engineering Co
MEC
$633M
| $4.75M | 0.01% |
774,058
+25,848
| +3% | +$194K |
|
402
ASML
ASML
$655B
| $4.7M | 0.01% |
17,964
-5,902
| -25% | -$1.68M |
|
|
KAMN
403
DELISTED
Kaman Corp
KAMN
| $4.69M | 0.01% |
+121,978
| New | +$6.89M |
|
404
TechnipFMC
FTI
$27.3B
| $4.68M | 0.01% |
934,111
-233,219
| -20% | -$2.56M |
|
405
LivePerson
LPSN
$27.3M
| $4.63M | 0.01% |
13,584
+1,569
| +13% | +$761K |
|
|
BMY.RT
406
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $4.63M | 0.01% |
+1,219,057
| New | +$4.02M |
|
407
Plains All American Pipeline
PAA
$16.6B
| $4.54M | 0.01% |
859,529
-589,890
| -41% | -$8.09M |
|
408
Nutrien
NTR
$31.9B
| $4.47M | 0.01% |
131,571
-29,949
| -19% | -$1.2M |
|
409
Revolution Medicines
RVMD
$42.4B
| $4.39M | 0.01% |
+200,490
| New | +$5.55M |
|
|
AY
410
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $4.32M | 0.01% |
+193,762
| New | +$5.23M |
|
411
Freeport-McMoran
FCX
$95.5B
| $4.29M | 0.01% |
636,284
-13,570
| -2% | -$142K |
|
|
NESR
412
National Energy Services Reunited Corp
NESR
$2.91B
| $4.18M | 0.01% |
823,689
+160,757
| +24% | +$1.17M |
|
413
Wheaton Precious Metals
WPM
$56.9B
| $4.05M | ﹤0.01% |
147,218
+11,759
| +9% | +$339K |
|
414
Kontoor Brands
KTB
$4.36B
| $3.99M | ﹤0.01% |
207,944
+7,203
| +4% | +$257K |
|
415
Wabtec
WAB
$49.9B
| $3.98M | ﹤0.01% |
+82,700
| New | +$5.68M |
|
|
NBL
416
DELISTED
Noble Energy, Inc.
NBL
| $3.81M | ﹤0.01% |
631,282
-3,967,555
| -86% | -$63.7M |
|
417
RenaissanceRe
RNR
$13.4B
| $3.74M | ﹤0.01% |
25,031
+4,333
| +21% | +$771K |
|
418
Air Products & Chemicals
APD
$66.8B
| $3.71M | ﹤0.01% |
+18,597
| New | +$4.24M |
|
419
Marathon Petroleum
MPC
$84B
| $3.59M | ﹤0.01% |
151,924
-78,443
| -34% | -$3.61M |
|
|
GTLS
420
DELISTED
Chart Industries
GTLS
| $3.58M | ﹤0.01% |
123,602
+16,276
| +15% | +$884K |
|
|
SCU
421
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $3.58M | ﹤0.01% |
+264,572
| New | +$5.69M |
|
|
BPMC
422
DELISTED
Blueprint Medicines
BPMC
| $3.57M | ﹤0.01% |
61,058
+416
| +0.7% | +$26.8K |
|
423
SLB Ltd
SLB
$76.5B
| $3.53M | ﹤0.01% |
261,541
-1,920,210
| -88% | -$55.6M |
|
424
Targa Resources
TRGP
$57.6B
| $3.53M | ﹤0.01% |
510,435
-1,685,158
| -77% | -$50.1M |
|
425
Constellium
CSTM
$3.88B
| $3.5M | ﹤0.01% |
672,458
+3,075
| +0.5% | +$33K |
|
Similar funds
Jennison Associates's Q1 2020 Portfolio in Review
As of Q1 2020, Jennison Associates held 749 positions worth $82.3B, down 17% from $99.1B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Jennison Associates withdrew a net $4.86B in Q1 2020, closing 131 positions and reducing 247 holdings. Its most notable exit was Parker-Hannifin, an estimated $116M position sold in full.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 27% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jennison Associates opened a new position in Atlassian worth $350M.
- Jennison Associates's largest Q1 2020 buy was Atlassian: 2,552,272 shares worth $350M.
- Jennison Associates added most to Eli Lilly in Q1 2020, an estimated $780M increase.
- Jennison Associates's biggest Q1 2020 reduction was Walt Disney, cutting an estimated $973M.
- Jennison Associates fully exited Parker-Hannifin in Q1 2020, selling an estimated $116M.
- Jennison Associates's ten largest holdings make up 40% of its $82.3B portfolio in Q1 2020.
- Jennison Associates opened 131 new positions and closed 131 in Q1 2020.
- Jennison Associates's portfolio value fell 17% quarter-over-quarter to $82.3B.
Based on Jennison Associates's 13F filing for Q1 2020, filed 6 May 2020.